0001209191-21-052810.txt : 20210820
0001209191-21-052810.hdr.sgml : 20210820
20210820172911
ACCESSION NUMBER: 0001209191-21-052810
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210625
FILED AS OF DATE: 20210820
DATE AS OF CHANGE: 20210820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: King Rachel K.
CENTRAL INDEX KEY: 0001589712
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 211194730
MAIL ADDRESS:
STREET 1: C/O GLYCOMIMETICS, INC.
STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-06-25
2021-06-29
0
0001000694
NOVAVAX INC
NVAX
0001589712
King Rachel K.
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock
2021-06-25
4
M
0
3450
A
6250
D
Restricted Stock Units
2021-06-25
4
M
0
3450
0.00
D
Common Stock
3450
3450
D
This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021.
Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2021-08-20